Aug 6, 2026 09:58AM
Aug 6, 2026 07:42AM
May 21, 2026 06:36AM
May 21, 2026 05:19AM
May 20, 2026 11:50AM
May 20, 2026 07:04AM
May 20, 2026 07:03AM Immunovant reports mixed trial results for IMVT-1402 in rheumatoid arthritis
Apr 2, 2026 11:58AM
Apr 2, 2026 11:16AM
Apr 2, 2026 10:15AM
Apr 2, 2026 06:54AM
Mar 20, 2026 08:38AM
Mar 20, 2026 08:38AM
Feb 6, 2026 07:05AM Immunovant, Inc. (IMVT) Tops Q3 EPS by 11c
Jan 26, 2026 03:29PM
Jan 6, 2026 05:34AM
Dec 11, 2025 03:58AM
Nov 21, 2025 08:05AM
Nov 11, 2025 05:57AM
Nov 10, 2025 07:32AM
Oct 14, 2025 06:06AM Truist Securities Starts Immunovant (IMVT) at Hold
Sep 4, 2025 06:24AM
Sep 3, 2025 12:58PM
Aug 11, 2025 12:19PM
Aug 11, 2025 11:44AM
Aug 11, 2025 11:02AM
Jul 25, 2025 07:34AM
Jul 10, 2025 06:29AM Goldman Sachs Resumes Immunovant (IMVT) at Neutral
May 30, 2025 06:41AM
Apr 21, 2025 07:02AM
Mar 20, 2025 12:01PM
Mar 20, 2025 06:39AM
Mar 20, 2025 06:35AM
Mar 20, 2025 06:07AM
Mar 19, 2025 07:45AM Roivant Sciences (ROIV) Announces Positive Results for Batoclimab Myasthenia Gravis and Chronic Inflammatory Demyelinating Polyneuropathy Studies
Mar 3, 2025 04:14AM
Feb 25, 2025 06:59AM
Feb 10, 2025 07:28AM
Feb 10, 2025 06:40AM
Jan 23, 2025 05:01AM
Jan 13, 2025 08:01AM
Jan 3, 2025 08:23AM Piper Sandler Explores Direct and Indirect Catalysts for Selected Biotechnology Companies
Dec 30, 2024 05:23PM
Oct 10, 2024 08:21AM
Oct 9, 2024 06:10AM
Sep 30, 2024 07:25AM
Sep 25, 2024 08:22AM
Sep 12, 2024 07:46AM
Sep 10, 2024 06:40AM H.C. Wainwright Reiterates Buy Rating on Immunovant (IMVT)
Sep 9, 2024 02:33PM

433,570 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All